Mount Sinai Alzheimer's Disease Research Center — New York, New York

Mount Sinai Alzheimer's Disease Research Center is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Alzheimer's Disease Research Center has participated in 2 clinical trials.

Therapeutic areas: Alzheimer Disease, Alzheimer's Disease.

Sponsors: Amylyx Pharmaceuticals Inc., Hillel Grossman.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Alzheimer's Disease Research Center?

Mount Sinai Alzheimer's Disease Research Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Alzheimer's Disease Research Center conducted?

Mount Sinai Alzheimer's Disease Research Center has 2 clinical trials on record. Their work covers Alzheimer Disease, Alzheimer's Disease.

Is Mount Sinai Alzheimer's Disease Research Center accredited by Crixeo Health?

Mount Sinai Alzheimer's Disease Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Alzheimer's Disease Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.